STAT1d
HIV self-testing is easy, effective — and underutilized
HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.
STAT3d
Gilead data suggest once-yearly shot of PrEP drug blocks HIV infection
Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...
Healio10h
Gilead encouraged by data on once-yearly lenacapavir for HIV prevention
New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...
Physician's Weekly4d
PrEP in Rural Areas: Integrating HIV Prevention & Harm Reduction
Utilizing syringe service programs to provide comprehensive PrEP care shows promise for encouraging more people who inject ...
The Washington Informer2d
Empowering Women and Girls: Advancing HIV Prevention
March is a significant month for women's health, observing International Women's Day and National Women's HIV/AIDS Awareness ...
STAT4d
Ending HIV requires changing how we talk – or don’t talk – about PrEP
In fact, in 2022, only 36% of people who could benefit from PrEP were prescribed it. vii HIV also continues to disproportionately affect certain regions of the country such as the Southern US and ...
Gilead presents data for once-yearly lenacapavir for HIV prevention
Sciences presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of ...